Viewing Study NCT05174169

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:13 PM
Ignite Modification Date: 2026-01-03 @ 6:42 PM
Study NCT ID: NCT05174169
Status: RECRUITING
Last Update Posted: 2025-12-02
First Post: 2021-12-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Sponsor: NRG Oncology
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stage III Colon Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ctDNA positive View
None ctDNA negative View
None Adjuvant Chemotherapy View
None Natera View
None Signatera View
None mFOLFOX6 View
None Stage III View
None CAPOX View
None mFOLFIRINOX View
None Oxaliplatin View
None 5-Fluorouracil (5-FU) View
None Capecitabine View
None Leucovorin View
None Irinotecan View
None Stage II View